Oxford Cannabinoid Technologies, which counts tobacco giant Imperial Brands Plc and rapper
The company, which develops cannabinoid-based prescription medicines, has raised 16.5 million pounds ($23 million) from wealthy individuals and institutional investors in a placing, giving it a market value of about 51.5 million pounds, Chairman
Oxford Cannabinoid, known as OCT, is hoping to replicate the success of
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.